SCHEMBL20176084

SCHEMBL20176084

C#C[Si](C)(C)OC(C)(C#N)CCc1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
OPRM1 P35372 1/20 0.35
DRD3 P35462 1/20 0.35
SGMS2 Q8NHU3 1/20 0.33
CTSK P43235 2/20 0.33
CTSS P25774 1/20 0.33
EBP Q15125 3/20 0.32
SIGMAR1 Q99720 3/20 0.32
LMNA P02545 2/20 0.31
USP2 O75604 1/20 0.31
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
PYCR1 P32322 1/20 0.31
ALDH1A1 P00352 2/20 0.31
NAAA Q02083 1/20 0.31
BLM P54132 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6724280 0.85 DRD2 (0.38) DRD2DRD4OPRM1DRD3SGMS2
SCHEMBL20176085 0.84 DRD2 (0.34) DRD2DRD4OPRM1DRD3SGMS2
SCHEMBL20176074 0.81 DRD2 (0.32) DRD2DRD4OPRM1DRD3SGMS2
SCHEMBL20176083 0.81 DRD2 (0.35) DRD2DRD4OPRM1DRD3SGMS2
SCHEMBL20176092 0.80 DRD2 (0.35) DRD2DRD4OPRM1DRD3SGMS2
SCHEMBL20176072 0.80 DRD2 (0.35) DRD2DRD4OPRM1DRD3SGMS2
SCHEMBL20176086 0.80 DRD2 (0.35) DRD2DRD4OPRM1DRD3SGMS2
SCHEMBL20176087 0.78 DRD2 (0.33) DRD2DRD4OPRM1DRD3EBP
SCHEMBL20176093 0.77 EBP (0.33) DRD2DRD4OPRM1DRD3CTSK
SCHEMBL20176091 0.77 CTSS (0.33) DRD2DRD4OPRM1DRD3CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450331-B2 Functionalized cyanosilane and synthesis method and use thereof EAST CHINA NORMAL UNIVERSITY (CN) 2019-10-22 US disclosed
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF EAST CHINA NORMAL UNIVERSITY (CN) 2018-05-24 US disclosed
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF EAST CHINA NORMAL UNIVERSITY (CN) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF NCLN, PNN, MB DRD2 2601/4885DRD4 2341/4885OPRM1 1704/4885
US-10450331-B2 Functionalized cyanosilane and synthesis method and use thereof NCLN, PNN, MB DRD2 2601/4885DRD4 2341/4885OPRM1 1704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.